期刊
JOURNAL OF CELL BIOLOGY
卷 176, 期 3, 页码 355-367出版社
ROCKEFELLER UNIV PRESS
DOI: 10.1083/jcb.200608167
关键词
-
类别
资金
- Medical Research Council [G0601946] Funding Source: Medline
- MRC [G0601946] Funding Source: UKRI
- Medical Research Council [G0601946] Funding Source: researchfish
We have discovered that fibrillin-1, which forms extracellular microfibrils, can regulate the bioavailability of transforming growth factor (TGF) beta 1, a powerful cytokine that modulates cell survival and phenotype. Altered TGF beta signaling is a major contributor to the pathology of Marfan syndrome (MFS) and related diseases. In the presence of cell layer extracellular matrix, a fibrillin-1 sequence encoded by exons 44-49 releases endogenous TGF beta 1, thereby stimulating TGF beta receptor-mediated Smad2 signaling. This altered TGF beta 1 bioavailability does not require intact cells, proteolysis, or the altered expression of TGF beta 1 or its receptors. Mass spectrometry revealed that a fibrillin-1 fragment containing the TGF beta 1-releasing sequence specifically associates with full-length fibrillin-1 in cell layers. Solid-phase and BIAcore binding studies showed that this fragment interacts strongly and specifically with N-terminal fibrillin-1, thereby inhibiting the association of C-terminal latent TGF beta-binding protein 1 ( a component of the large latent complex [LLC]) with N-terminal fibrillin-1. By releasing LLC from micro. brils, the fibrillin-1 sequence encoded by exons 44-49 can contribute to MFS and related diseases.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据